Tango Therapeutics, Inc. (TNGX) Earnings Call Transcripts

9 earnings calls from January 2023 to October 23, 2026

NasdaqGM US Health Care Biotechnology

About Tango Therapeutics, Inc.

Tango Therapeutics, Inc. (TNGX) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 9 calls on record spanning January 18, 2023 to October 23, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 9 Tango Therapeutics, Inc. earnings call transcripts on record, spanning January 18, 2023 to October 23, 2026. Based on this history, Tango Therapeutics, Inc. reports semi-annually. The most recent call on file is dated October 23, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
TNGX
Exchange
NasdaqGM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
9
First call
January 18, 2023
Most recent
October 23, 2026
Reporting cadence
semi-annually
Quarter Date
Special Calls Oct 23, 2026 Read transcript →
Special Calls Jun 8, 2026 Read transcript →
Company Conference Presentations Jan 14, 2026 Read transcript →
Special Calls Oct 23, 2025 Read transcript →
Company Conference Presentations Sep 17, 2024 Read transcript →
Company Conference Presentations Jun 11, 2024 Read transcript →
Company Conference Presentations Mar 13, 2024 Read transcript →
Company Conference Presentations Jun 9, 2023 Read transcript →
Company Conference Presentations Jan 18, 2023 Read transcript →